Creative Medical Technology Holdings, Inc. (CELZ) DCF Valuation

Creative Medical Technology Holdings, Inc. (CELZ) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Creative Medical Technology Holdings, Inc. (CELZ) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Streamline your analysis and improve precision with our (CELZ) DCF Calculator! Utilizing real data from Creative Medical Technology Holdings, Inc. and customizable assumptions, this tool empowers you to forecast, analyze, and value (CELZ) just like a seasoned investor.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .2 .2 .1 .1 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -0.60423 -46.65 0.96406 -89.84 -34.03 -34.03 -34.03 -34.03 -34.03
EBITDA -1.1 -1.0 -3.0 -10.2 -5.5 .0 .0 .0 .0 .0
EBITDA, % -666.6 -637.11 -3457.24 -11458.56 -61394.98 -100 -100 -100 -100 -100
Depreciation .0 .1 .1 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 16.28 40.6 104.93 103.93 1050.93 71.38 71.38 71.38 71.38 71.38
EBIT -1.1 -1.1 -3.1 -10.2 -5.6 .0 .0 .0 .0 .0
EBIT, % -682.88 -677.71 -3562.17 -11562.5 -62445.91 -100 -100 -100 -100 -100
Total Cash .1 .1 10.7 18.4 10.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .1 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 3.38 0 2.83 0 0
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 12.38 11.51 73.27 19.43 19.43 19.43 19.43 19.43
Accounts Payable .3 .4 .8 3.3 .3 .0 .0 .0 .0 .0
Accounts Payable, % 193.83 213.31 868.18 3687.97 3525.33 100 100 100 100 100
Capital Expenditure .0 -.3 .0 .0 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % 0 -151.98 0 0 -1111.11 -40 -40 -40 -40 -40
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -1.4 -1.2 -2.4 -10.1 -5.6 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -1.0 -1.3 -1.9 -7.5 -8.6 -.3 .0 .0 .0 .0
WACC, % 28.08 28.08 28.08 28.08 28.08 28.08 28.08 28.08 28.08 28.08
PV UFCF
SUM PV UFCF -.2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -3
Equity Value 3
Diluted Shares Outstanding, MM 1
Equity Value Per Share 2.29

What You Will Get

  • Pre-Filled Financial Model: Creative Medical Technology Holdings, Inc.'s (CELZ) actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
  • Instant Calculations: Automatic updates provide real-time results as you adjust inputs.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation presentations.
  • Customizable and Reusable: Designed for adaptability, enabling repeated use for comprehensive forecasts.

Key Features

  • Comprehensive Data: Access Creative Medical Technology Holdings, Inc.’s (CELZ) historical financial reports and projected forecasts.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Insights: Watch the intrinsic value of Creative Medical Technology Holdings, Inc. (CELZ) update instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics clearly.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Step 1: Download the Excel file for Creative Medical Technology Holdings, Inc. (CELZ).
  2. Step 2: Examine the pre-filled financial data and projections for CELZ.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose This Calculator for Creative Medical Technology Holdings, Inc. (CELZ)?

  • User-Friendly Interface: Perfectly crafted for both novices and seasoned users.
  • Customizable Inputs: Adjust parameters effortlessly to suit your analysis needs.
  • Real-Time Feedback: Observe immediate updates to CELZ’s valuation as you modify inputs.
  • Pre-Loaded Data: Comes equipped with Creative Medical’s latest financial information for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Investors: Accurately evaluate Creative Medical Technology Holdings, Inc.'s (CELZ) fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for financial analysis and reporting related to (CELZ).
  • Consultants: Efficiently customize the template for valuation reports tailored to clients interested in (CELZ).
  • Entrepreneurs: Acquire knowledge on financial modeling strategies employed by leading companies, including (CELZ).
  • Educators: Implement it as a teaching resource to illustrate valuation techniques applicable to (CELZ).

What the Template Contains

  • Historical Data: Includes Creative Medical Technology Holdings, Inc.'s (CELZ) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Creative Medical Technology Holdings, Inc.'s (CELZ) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital specific to Creative Medical Technology Holdings, Inc. (CELZ).
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions relevant to Creative Medical Technology Holdings, Inc. (CELZ).
  • Quarterly and Annual Statements: A complete breakdown of Creative Medical Technology Holdings, Inc.'s (CELZ) financials.
  • Interactive Dashboard: Visualize valuation results and projections for Creative Medical Technology Holdings, Inc. (CELZ) dynamically.

Es wurden keine passenden Produkte gefunden.